Peter Richmond

14.5k total citations
328 papers, 8.4k citations indexed

About

Peter Richmond is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Peter Richmond has authored 328 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 234 papers in Epidemiology, 121 papers in Microbiology and 50 papers in Infectious Diseases. Recurrent topics in Peter Richmond's work include Pneumonia and Respiratory Infections (144 papers), Respiratory viral infections research (124 papers) and Bacterial Infections and Vaccines (118 papers). Peter Richmond is often cited by papers focused on Pneumonia and Respiratory Infections (144 papers), Respiratory viral infections research (124 papers) and Bacterial Infections and Vaccines (118 papers). Peter Richmond collaborates with scholars based in Australia, United Kingdom and United States. Peter Richmond's co-authors include David Burgner, Helen Marshall, Ray Borrow, Tobias Strunk, Andrew Currie, Karen Simmer, Hannah C. Moore, Christopher C. Blyth, Deborah Lehmann and Elizabeth Miller and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Peter Richmond

315 papers receiving 8.1k citations

Peers

Countries citing papers authored by Peter Richmond

Since Specialization

Citations

This map shows the geographic impact of Peter Richmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Richmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Richmond more than expected).

Fields of papers citing papers by Peter Richmond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Richmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Richmond. The network helps show where Peter Richmond may publish in the future.

Co-authorship network of co-authors of Peter Richmond

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Richmond. A scholar is included among the top collaborators of Peter Richmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Richmond. Peter Richmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents 2024 ·Vaccine ·Peter Richmond, Terry Nolan, (unknown), (unknown), Joshua Kim, (unknown), (unknown), John D. Campbell, Olivier Godeaux, Ouzama Henry, Nicholas Wood, Robert S. Janssen	1
2	Parental awareness and attitudes towards prevention of respiratory syncytial virus in infants and young children in Australia 2024 ·Acta Paediatrica ·(unknown), (unknown), (unknown), (unknown), Peter Richmond, Samantha Carlson, Hannah C. Moore	9
3	A Phase 1/2a Study Evaluating Safety and Immunogenicity of Ad26.RSV.preF in RSV-seronegative Toddlers Aged 12–24 Months 2024 ·Open Forum Infectious Diseases ·Joanne M. Langley, Terry Nolan, Mika Rämet, Peter Richmond, Nelson Augusto Rosário Filho, Wouter Haazen, (unknown), Kristi L. Williams, Arangassery Rosemary Bastian, (unknown), (unknown), (unknown), (unknown), Wilbert van Duijnhoven, Esther Heijnen, Benoît Callendret	2
4	An infant mouse model of influenza-driven nontypeable Haemophilus influenzae colonization and acute otitis media suitable for preclinical testing of novel therapies 2024 ·Infection and Immunity ·(unknown), (unknown), Kelly M. Martinovich, Naomi M. Scott, Elke Seppanen, (unknown), Deborah H. Strickland, Alma Fulurija, Peter Richmond, Lea‐Ann S. Kirkham	1
5	Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial 2024 ·PLoS Medicine ·(unknown), Marie J. Estcourt, (unknown), Julie Marsh, Kirsten P. Perrett, Dianne E. Campbell, Nicholas Wood, Michael R. Gold, Claire S. Waddington, (unknown), (unknown), Nigel Curtis, Mark Jones, Peter McIntyre, Patrick G. Holt, Peter Richmond, Tom Snelling	2
6	Determining the true incidence of seasonal respiratory syncytial virus-confirmed hospitalizations in preterm and term infants in Western Australia 2023 ·Vaccine ·Mohinder Sarna, Amanuel Tesfay Gebremedhin, Peter Richmond, Avram Levy, Kathryn Glass, Hannah C. Moore	1
7	Global Prevalence of Varicella-Associated Complications: A Systematic Review and Meta-Analysis 2023 ·Infectious Diseases and Therapy ·Hiral Shah, (unknown), (unknown), G. Casabona, Peter Richmond, (unknown)	9
8	A Review of Cardiac Surgical Procedures and Their Outcomes for Paediatric Rheumatic Heart Disease in Western Australia 2023 ·Heart Lung and Circulation ·(unknown), Judith Katzenellenbogen, David Andrews, Jonathan R. Carapetis, Peter Richmond, E. McKinnon, James Ramsay	0
9	An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol 2022 ·Vaccines ·Helen Marshall, Prabha H. Andraweera, James Ward, John Kaldor, Ross Andrews, Kristine Macartney, Peter Richmond, Vicki Krause, Ann P. Koehler, David M. Whiley, Lynne Giles, (unknown), (unknown), Jonathan Karnon, Rob Baird, Andrew J. Lawrence, Helen Petousis‐Harris, Philippe De Wals, (unknown), Michael Binks, Lisa J Whop	7
10	A Prospective Study Investigating the Impact of Obesity on the Immune Response to the Quadrivalent Influenza Vaccine in Children and Adolescents 2022 ·Vaccines ·Michelle Clarke, (unknown), Lynne Giles, Alexia Peña, Ian Barr, Peter Richmond, Helen Marshall	9
11	Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study 2022 ·Blood Advances ·Charles T. Quinn, Richard T. Wiedmann, Daniel Jarovsky, Eduardo López‐Medina, (unknown), (unknown), (unknown), Qiong Shou, Ron Dagan, Peter Richmond, Kristen A. Feemster, Richard McFetridge, Gretchen Tamms, Robert Lupinacci, Luwy Musey, Kara Bickham	6
12	Australian Aboriginal children have higher hospitalization rates for otitis media but lower surgical procedures than non-Aboriginal children: A record linkage population-based cohort study 2019 ·PLoS ONE ·(unknown), Deborah Lehmann, (unknown), Peter Richmond, Francis J. Lannigan, Parveen Fathima, Christopher C. Blyth, Hannah C. Moore	7
13	SCN1A Variants in vaccine‐related febrile seizures: A prospective study 2019 ·Annals of Neurology ·John A. Damiano, Lucy Deng, Wenhui Li, Rosemary Burgess, Amy Schneider, Nigel W. Crawford, Jim Buttery, Michael Gold, Peter Richmond, Kristine Macartney, Michael S. Hildebrand, Ingrid E. Scheffer, Nicholas Wood, Samuel F. Berkovic	18
14	The impact of influenza infection on young children, their family and the health care system 2018 ·Influenza and Other Respiratory Viruses ·(unknown), David B. Preen, Peter Richmond, Peter Jacoby, Paul V. Effler, David W. Smith, (unknown), Meredith L Borland, Avram Levy, Anthony D. Keil, Christopher C. Blyth, (unknown)	31
15	Group A Streptococcal Carriage and Seroepidemiology in Children up to 10 Years of Age in Australia 2015 ·The Pediatric Infectious Disease Journal ·Helen Marshall, Peter Richmond, Michael D. Nissen, Stephen B. Lambert, Robert Booy, Graham Reynolds, Shite Sebastian, Michael W. Pride, (unknown), Annaliesa S. Anderson, Ingrid L. Scully	16
16	Predictors of Disease Severity in Children Hospitalized for Pertussis During an Epidemic 2014 ·The Pediatric Infectious Disease Journal ·Helen Marshall, Michelle Clarke, (unknown), Peter Richmond, Jim Buttery, Graham Reynolds, Ross Andrews, Michael D. Nissen, Nicholas Wood, Peter McIntyre	57
17	Phagocytosis of neonatal pathogens by peripheral blood neutrophils and monocytes from newborn preterm and term infants 2013 ·Pediatric Research ·Amy Prosser, Julie Hibbert, Tobias Strunk, Chooi Kok, Karen Simmer, Peter Richmond, David Burgner, Andrew Currie	45
18	Histologic Chorioamnionitis Is Associated With Reduced Risk of Late-Onset Sepsis in Preterm Infants 2011 ·PEDIATRICS ·Tobias Strunk, Dorota A. Doherty, Angela Jacques, Karen Simmer, Peter Richmond, Rolland Kohan, Adrian Charles, David Burgner	93
19	SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine 2011 ·Vaccine ·(unknown), Peter Richmond, Siew‐Kim Khoo, Guicheng Zhang, Stephanie T. Yerkovich, Peter N. Le Souëf, Catherine M. Hayden	25
20	Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children 2010 ·The Pediatric Infectious Disease Journal ·Heath Kelly, Peter Jacoby, (unknown), Dale Carcione, Simon H. Williams, Hannah C. Moore, David W. Smith, Anthony D. Keil, Paul Van Buynder, Peter Richmond	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact